Research programme: skin disorder therapy - Handok Inc.Alternative Names: HL5945
Latest Information Update: 04 Dec 2015
At a glance
- Originator Handok Inc
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Alopecia
Most Recent Events
- 04 Dec 2015 Early research in Alopecia in South Korea (unspecified route)